10 immunotherapy companies making waves in 2023
Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is…
The idea that our immune system can be rewired to fight cancer has resulted in huge expectations and an influx of investments into the immuno-oncology field. Following the market success of immune checkpoint inhibitors, more and more attention is turning to CAR-T cell therapy, with the first CAR-T therapy, Novartis’ Kymriah, approved in 2017.
With five CAR-T therapies on the global market already and over hundreds of clinical trials currently running, the field is now booming. Read on to keep up-to-date with the evolving CAR-T cell therapy market and ongoing research.
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportImmunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is…
A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable…
Peter MacCallum Cancer Centre (Peter Mac) in Australia and Cartherics Pty Ltd have entered into…
The Sheba Medical Center in Israel has an advanced hemato-oncology center that offers in-house CAR…
Chimeric antigen receptor-T cell (CAR-T) therapy is an exciting treatment modality for blood cancers that…
Poolbeg Pharma has announced the strategic expansion of POLB 001 into oncology. POLB 001 is…
Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer,…
A MedUni Vienna research team in Austria has discovered a new highly potent biomarker for…
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial…
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
A new case of blood cancer gets diagnosed approximately every three minutes in Western countries.…
Legend Biotech Corporation has announced that the U.S. Food and Drug Administration (FDA) has cleared…